Vol. 33, No. 3, 1968
BlOCHEMlCAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
ENZYMATIC CONVERSION OF ’ 4-CBOLESTADIEN-3&OL
A83
TO
CHOLESTEROL1
Barry
and ChmicaZ
N. Lutsky
and G. J.
Division of Biochemistry, Engineering, University
Schroepfer,
Department of Illinois,
Jr.
of
chemistry Urbana, ItI.
61801
Received October 2, 1968
The of
nature
of
cholesterol
vious
has
as
double
A5,7-
and
,
removal
As.
of
the
led
two
role
of
A*(14)-sterols
is
this of
further
finding
1.
have
laboratory
to
to
(Lee
enzymatic
This work National
removal
was Heart
of
supported Institute.
and
group
a grant
492
the
enzymatic
of
lanosterol
intermediary
cholesterol.
in
Fried,
rat
liver
of
1968)
also
homo-
preparations
been
consideration
methyl
14
AT-,
possible
Schroepfer,
in
by
with
sterols
4,4-dimethyT-68(14)-
similar
has
the
of
of
of that
with
significance
1967))
atom
cholesterol
A8(14)-cholesten-3B-ol of
carbon the
shown
studies
Schroepfer,
A8-,
mechanism
biosynthesis
convertible In
the
investigate the
(1968)
preparations.
version
the
in
Pre-
positions:
attached to
and
a number
of
group
formation
laboratories. (Frantz
following
Considerations
and Brown
in
the
enzymatic
several
intermediates
laboratories
cholesten-36-01
liver
in
methyl
have
Dudowjtz,
in
the
elsewhere
probable
bonds
in
studied
reviewed
implicated
nuclear
intermediates
been
publications,
have
genate
the
the
(HE-09501)
facile
con-
demonstrated. of
attached
rat
the to
from
A
mechanism carbon
the
atom
of 14
Vol.
33,
No.
of
BIOCHEMICAL
3, 1968
lanosterol
is
that
the
to
cholesterol.
recent
158-hydrogen
As by
the
an
this
our
its
of
preparations.
to
We wish of
Synthesis
this
of
9 infrared
scopy,
mass
these
impregnated
of
techniques:
very
152’)
by
and
silica
1567),
gel
acetone (E
with
prepared
oxidation purified
from
potassium
by
were
ultraviolet
spectro-
resonance
spectro-
on
chromato-
plates
of
(Kammereck,
neutral
Lee,
chromatographic
(m.p. from
Paliokas
analysis
(3%
of
(Fieser
and
the
acetate
prisms,
chromium column
trioxide
chromatography
99.5
-
101.5’;
X
A5,7-cholestadien-3B-ol acetic
by The
m.p.
free
113.5
on
493
under
-
pyridine alumina,
anhydride,
reflux
crystal 0
114.5
;
prepared at
with 1 ized
XEtOH from
4’. and
l51-
Aa,14-cholestadien-
sterol
was in
acetic
1953). heating
EtOH (m.p.
acid,
Ourisson,
Aa,14-cholestadien-3-one with
homogenate
thin-layer
and
gas-liquid
hydroxide.
elongated
18,000).
as-
enzymatic
magnetic
nitrate
a mixture
acid
in
to
liver
point,
G plates
prepared
treatment
methanolic
prepared
intermediates
analysis,
silver and
18,lQQ))was
was
have
Q).
hydrochloric
38-01
rat
efficient
melting
Aa~14-cholestadienyl-3f3-acetate (E
we
following
nuclear
with
gas-chrom
mu
stimulated
hydrogen by
the
elemental
on
Schroepfer,
250
al.
conversion
cholesterol.
purity
spectroscopy,
alumina
on
--et
(1368)
enzymatic
clearly
isotopic
the
spectroscopy,
analysis
QF-1
to
and
graphic
and
and
al.
Aa~14-choZestadien-3-one
by
scopy
work
COMMUNICATIONS
et
upon
cholesterol
report
sterol
Authenticity determined
to
lost
with
RESEARCH
Canonica
Canonica
labeled
convertibility
conversion
is
previous
observation
A*,14-cholestadien-3b-ol certain
by
lanosterol
of
important
BIOPHYSICAL
observation
of
extension
AND
from
250 the
The crystallization
15%
mu alcohol
ketone
by was
Vol. 33,No.
3, 1968
from
BIOCHEMICAL
methanol-ether
yielding
AEtoH 250 mu
133.5O;
Synthesis
250
liquid
mu
aluminum
(E
18,100);
by and
nitrate
(2)
digitonide
The
specific
in
in
propylene x
g
3 hours
in
air
sterols
were
extraction
further
and
was
39.9
mc/mmole.
of
96%
plates
of
lithium
silica
basis
an
from
methanol.
radiopurity
of
was
analysis
G and
by
aiumina-
1968),
ization The
gel
on
Schroepfer,
recrystall
the
gas-
A8~14-
by
thin-layer
gas-liquid
- A8*14-cholestadien-3G-ol (100
supernatant at
37’
isolated
chroma-
from
they
nitrate
(98~2) is
as
shown
radioactivity
characterized
and the
the
eluting
34
cm)
of
I.
by
purification
494
of
a for
by
incubated
radio-
on
an
of
chloroform
alumina-
resulting 75%
of
chromatographically in
107
The
the
a mixture
Approximately
associated
ml
medium
chromatography
The
x
homogenate 1968).
solvent.
Figure
such
liver
2.1 30
incubation
using
cholesterol as
rat
Schroepfer,
to
x
labeled
a
pg; with
(88% recovery
(1
in
incubated
saponified
subjected
was The
was of
ether
were
column
~1)
(Paliokas
to choZestero2
(148.5
fraction
petroleum
and
acetone
A83 14-choleetadien-3~-ol preparations.
glycol
with
activity)
cholesterol.
Lee,
on
from
chromatography
(3)
homogenate
10,000
covered
(1)
- 114.2’; and
of [~CX- 34 -
130- 3Hl
chromatogram
-
.
liver
silver
137
thin-layer
tritium-labeled
and
excess on
Comersion
cpm)
by
on
prepared
with
(Paliokas,
activity be
was
purified
formation,
to
by rat
m.p.
(m.p. 113.5
component
reduction
column
chromatography
and
single analyses)
hydride
tog raphy
needles,
A8*14-cholestadien-3@-ol
-
cholestadien-j-one
judged
compact
18,200).
(E
chromatographic
silver
short,
RESEARCH COMMUNICATIONS
of L3c.x- 3Hl - A8, 14-cholestadien-3&3-ol
[3a - 3H] hEtOH
AND BIOPHYSICAL
the with
fractions
62-75 by
re-
way
of
was the
dibromide
Vol.
33,
No.
BIOCHEMICAL
3, 1968
AND
FRACTION
Figure
2.
BIOPHYSICAL
RESEARCH
NUMBER
chxomatogrwn showing enzymatic
Column
13a - “HI - A83 14-chdesten-3fho~ A-d, OV, radioactivity; colorimetricaZZy;
COMMUNICATIONS
of
conversion
to cholesterol.
measured
choZe.sterol Aa, ’ 4-cho~estcdien-
A-A,
38-ol measured coZorimetricalZy.
(Paliokas
and
terol
.
were
67,000
the
radioactivity
column of
The
mobility
activities 67,800
a
less
material
These to
the
biosynthesis
the
peak
has
not
after
dilution
before
and
and studies
by
were suggests
negative. a
of
after
this
choles-
purification
tritium)
emerged
3.5-45).
determined.
amount
The ‘27
from
precise
-sterols
of
the nature
with
similar
Aa(14)-cholesten-3b-ol,
cholestan-3b-01.
establish
cholesterol
unlabeled
A significant
recovered (fractions
been
with
respectively.
ha-cholesten-3b-01,
controls
conversion
of
polar
A7-cholesten-3b-01,
enzyme
cpm/mg,
(10%
include
vertible
1368)
specific and
in
this
Schroepfer,
possible
rat
that
Aa,14-cholestadien-3b-ol
liver
homogenate
The
cholesterol.
495
preparations.
efficient
intermediary
is
nature role
of
of this
conBoi led
the
observed
compound
in
Vol. 33, No. 3, 1968
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
References
Canonica,
L., Grossi 90, L.F., I.D.,
Fieser, Frantz,
Fiecchi, A., Galli Paoletti, E., and 3597 (1968). and Ourisson, G., Jr., and Schroepfer,
Kienle, Paoletti,
M., R.,
Scala, J.
A., Am.
Galli, G., Cbm. Sot.,
J. Am. Chem. Sot., 15, 4404 (1953). G.J., Jr., Ann. Review Biochem.,
36, 691 (1967). Fried,
J.,
Dudowitz,
A.,
Commun., 2, Kammereck, Lee,
W.,
Paliokas,
R.,
Lee,
and
Brown,
J.W.,
Biochem.
Biophys.
W.,
Paliokas,
A.,
and
Schroepfer,
G.J.,
J. lipid? Res., g, 282 (1967). and Schroepfer, G.J., Jr., Biochem. Biophys. 32, 635 (1968). A.M.,
Res.
568 (1968).
Lee,
W.,
and
Schroepfer,
G.J.,
Jr.,
Jr.,
Res. Comnun., J.
Lipid
Res.,
2, 143 (1968). Pal iokas,
A.M.,
and
Schroepfer,
G.J.,
(1968).
496
Jr.,
J. Biol.
Chem.. 3,
453